Thelansis

  Androgenetic alopecia, a condition with a genetic predisposition, is characterized by an exaggerated response to androgens, affecting around 50% of both men and women. It entails a gradual loss of scalp hair, typically commencing after puberty, exhibiting a discernible pattern in both genders. Androgenetic alopecia primarily stems from an overreaction to androgens, which triggers a shortened growth phase (anagen) in the normal hair growth cycle, leading to follicular miniaturization. Diagnosis usually relies on clinical assessment, considering a history of gradual onset post-puberty and sometimes a family history of baldness. Treatment options approved by the FDA for pattern baldness include topical minoxidil and finasteride. These treatments necessitate consistent application for at least 4 to 6 months before noticeable improvements are seen and require ongoing, indefinite usage to maintain results. Unlike antiandrogen agents, finasteride acts as a 5 alpha-reductase type 2 inh...